Related Experiment Videos
Iodinated vancomycin and mucopeptide biosynthesis by cell-free preparations from Micrococcus lysodeikticus
The Biochemical Journal
|October 1, 1970
Summary
Vancomycin antibiotic inhibits bacterial cell wall mucopeptide synthesis by binding to d-alanyl-d-alanine. Penicillin preserves these binding sites, increasing vancomycin affinity.
Area of Science:
- Microbiology
- Biochemistry
- Pharmacology
Background:
- Bacterial cell wall synthesis is a target for antibiotics.
- Mucopeptide is a key component of bacterial cell walls.
- Vancomycin and penicillin are important antibiotics affecting cell wall synthesis.
Purpose of the Study:
- To investigate the mechanism of vancomycin and penicillin on mucopeptide synthesis.
- To identify the specific binding sites of vancomycin on bacterial preparations.
- To elucidate the role of terminal d-alanyl-d-alanine in antibiotic action.
Main Methods:
- Utilized a particulate preparation from Micrococcus lysodeikticus for mucopeptide synthesis.
- Employed radioactive iodinated vancomycin to track binding.
- Analyzed mucopeptide products (soluble and insoluble fractions) for vancomycin affinity and lysozyme sensitivity.
Main Results:
- Vancomycin binding to the preparation inhibited mucopeptide synthesis.
- Newly synthesized mucopeptide exhibited increased vancomycin binding, indicating new d-alanyl-d-alanine termini.
- Penicillin treatment of insoluble mucopeptide resulted in conserved d-alanyl-d-alanine termini, enhancing vancomycin affinity.
Conclusions:
- Vancomycin inhibits mucopeptide synthesis by binding to the d-alanyl-d-alanine terminus.
- Penicillin's effect on cell wall synthesis involves the conservation of these terminal residues.
- Understanding these interactions is crucial for developing new antibacterial strategies.